SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
Vous n'êtes pas connecté
RVTY is likely to see another earnings beat as Diagnostics momentum and Signals Software growth offset tariff headwinds.
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
AXON eyes another earnings beat as TASER, body cameras and cloud services drive strong Q2 growth across key segments.
Revvity's second-quarter results showcase strong growth in its Diagnostics business, along with recovery in Life Sciences segmental sales.
Revvity's second-quarter results showcase strong growth in its Diagnostics business, along with recovery in Life Sciences segmental sales.
COMM Q2 earnings beat estimates as revenues jump 31.7%, fueled by strong demand across all segments and innovation-driven growth.
COMM Q2 earnings beat estimates as revenues jump 31.7%, fueled by strong demand across all segments and innovation-driven growth.
AEP posts an 11.7% Q2 earnings beat and 11.1% revenue growth, driven by strong performance across all core segments.